018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity

Smith, G C ; Kotwinski, P ; Sanders, J ; Cooper, J ; Ma, L ; Jones, A ; Mythen, M G ; Montgomery, H E ; Pennell, D J

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A12 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and British Cardiovascular Society

Texto completo disponível